Owkin France

General information
Owkin France
12 Rue Martel
Ile-de-France
75010 Paris, Paris
France

Contact person: Philippe de Vom├ęcourt, Strategy Manager
Website:  https://owkin.com
Source of foundation:Subsidiary
Name of foundation source:Owkin, USA
Corporate description / mission:
Owkin uses artificial intelligence to find the right treatment for every patient. We use AI to identify new drug candidates, de-risk and accelerate clinical trials and build diagnostic tools that improve patient outcomes. Using federated learning, Owkin unlocks valuable insights from siloed datasets, while protecting patient privacy and securing proprietary data.
Owkin was co-founded by Thomas Clozel MD and Gilles Wainrib in 2016, and now works with the most prominent cancer centers and biopharma companies in Europe and the US. It has raised over $255 million, becoming a unicorn in November 2021
State of ownership: Private / independent
Headquarters: No
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Bioinformatics
  • Genomics
Business model:
  • R&D
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Summary Products / Services / Technologies
Technology used:
OWKIN Socrates
X